Pharma appeals to Ukraine Health Ministry on insulin supply problems

The Association of Pharmaceutical Research and Development (APRaD) and the American Chamber of Commerce (AmCham) in Ukraine have recently sent an open letter to the Minister of Health of Ukraine, which aimed to draw attention to the problems of providing patients with insulin and their possible solutions.

According to the letter, the primary purpose of improving the system of providing patients with medicines they need are to reduce the incidence of complications and mortality from diabetes, to improve the quality of patients’ life and to reduce government spending on the treatment of late complications of diabetes. Thus, due to the position of AmCham and APRaD, the approach to the problem must be comprehensive and aimed at removing barriers of patient access to needed treatment, they said.

The following approaches of solving these problems were offered in the open letter: